Literature DB >> 20058913

Degradation of poly(glycoamidoamine) DNA delivery vehicles: polyamide hydrolysis at physiological conditions promotes DNA release.

Yemin Liu1, Theresa M Reineke.   

Abstract

Poly(glycoamidoamine)s (PGAAs) are a group of efficient and degradable gene delivery vehicles that consist of three main functionalities: carbohydrate groups, secondary amines, and amide bonds. Herein, we have created nonhydroxylated models to these structures by polymerizing oxylate, succinate, or adipate groups with pentaethylenehexamine. The resulting polymers (named O4, S4, and A4, respectively) were created to understand how the absence of hydroxyl groups and changes in the amide bond spacing affect polymer degradation, plasmid DNA (pDNA) complexation, toxicity, and transfection efficiency in vitro. An additional model was also created that retains a galactaramide unit, but we have replaced the secondary amines with ethyleneoxide units (GO2) to understand the effects of the amine groups on polymer degradation. We have found that the secondary amines and hydroxyls are necessary to facilitate rapid degradation of these polymers, and analogues lacking hydroxyls or amines did not degrade over the time course of the study. Through electron-withdrawing and hydrogen bonding, the hydroxyls appear to activate the carbonyls of the amide bond to hydrolysis via an inductive electron withdrawing effect. Through titration experiments, PGAA degradation appears not to affect the polymer buffering capacity. Furthermore, we have found that PGAA degradation may enhance gene expression by releasing pDNA from polyplexes (polymer-pDNA complexes) and, thus, exposing it to undergo transcription and translation. The difference in the optimal pH that promotes degradation of the PGAAs and the hydroxyl-free analogues may prove to be a useful means to achieve pH-regulated DNA release from polyplexes by specifically modulating the chemical structures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20058913     DOI: 10.1021/bm9008233

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  14 in total

Review 1.  Synthetic Biomaterials from Metabolically Derived Synthons.

Authors:  Nicole G Ricapito; Cynthia Ghobril; Heng Zhang; Mark W Grinstaff; David Putnam
Journal:  Chem Rev       Date:  2016-01-29       Impact factor: 60.622

Review 2.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

3.  Spatiotemporal cellular imaging of polymer-pDNA nanocomplexes affords in situ morphology and trafficking trends.

Authors:  Nilesh P Ingle; Lian Xue; Theresa M Reineke
Journal:  Mol Pharm       Date:  2013-09-30       Impact factor: 4.939

4.  Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms.

Authors:  Katye M Fichter; Nilesh P Ingle; Patrick M McLendon; Theresa M Reineke
Journal:  ACS Nano       Date:  2012-12-31       Impact factor: 15.881

5.  Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties.

Authors:  Joel C Sunshine; Daniel Y Peng; Jordan J Green
Journal:  Mol Pharm       Date:  2012-09-27       Impact factor: 4.939

6.  Poly(glycoamidoamine) brush nanomaterials for systemic siRNA delivery in vivo.

Authors:  X Luo; W Wang; J R Dorkin; O Veiseh; P H Chang; I Abutbul-Ionita; D Danino; R Langer; D G Anderson; Y Dong
Journal:  Biomater Sci       Date:  2016-12-20       Impact factor: 6.843

7.  In vivo delivery of nucleic acids via glycopolymer vehicles affords therapeutic infarct size reduction in vivo.

Authors:  Michael Tranter; Yemin Liu; Suiwen He; James Gulick; Xiaoping Ren; Jeffrey Robbins; W Keith Jones; Theresa M Reineke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

8.  Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo.

Authors:  Yizhou Dong; J Robert Dorkin; Weiheng Wang; Philip H Chang; Matthew J Webber; Benjamin C Tang; Junghoon Yang; Inbal Abutbul-Ionita; Dganit Danino; Frank DeRosa; Michael Heartlein; Robert Langer; Daniel G Anderson
Journal:  Nano Lett       Date:  2016-01-13       Impact factor: 11.189

9.  Exploring the mechanism of plasmid DNA nuclear internalization with polymer-based vehicles.

Authors:  Giovanna Grandinetti; Theresa M Reineke
Journal:  Mol Pharm       Date:  2012-07-09       Impact factor: 4.939

10.  Poly(galactaramidoamine) is an efficient cationic polymeric non-viral vector with low cytotoxicity for transfecting human embryonic kidney (HEK293) and murine macrophage (RAW264.7) cells.

Authors:  Amaraporn Wongrakpanich; Vijaya B Joshi; Aliasger K Salem
Journal:  Pharm Dev Technol       Date:  2012-01-12       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.